RxDoctor Payments Data

Jacob West, PA

Physician Assistant · Alcoa, TNNPI 1427533488

Payments from drug & device makers

$1,204in general payments, 2019–2025

Across 59 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$279
  • Pfizer$200
  • AstraZeneca$146
  • Novo Nordisk$133
  • Esperion Therapeutics, Inc.$75
  • Boehringer Ingelheim$67
  • plus $304 from 9 others

What the payments were for

  • Food & beverage$1,204100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,204 in reported general payments places this provider in the 70th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$42,484
Medicare patients
177
Services billed
652

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$60,276
MounjaroTirzepatide42$52,312
OzempicSemaglutide32$30,906
TrulicityDulaglutide19$27,399
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$22,224
JardianceEmpagliflozin17$15,904
TrintellixVortioxetine Hydrobromide12$5,559
Esomeprazole Magnesium15$1,873
Potassium Chloride62$1,529
Omeprazole96$1,347
Testosterone Cypionate32$1,322
Albuterol Sulfate HfaAlbuterol Sulfate43$1,253
Atorvastatin Calcium134$1,131
Duloxetine Hcl47$1,121
Rosuvastatin Calcium116$1,094

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$279$79,71161 claims
PfizerEliquis$200$60,27676 claims
Novo NordiskOzempic$133$30,90632 claims
GSKTrelegy Ellipta$27$22,22423 claims
Boehringer IngelheimJardiance$67$15,90417 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Alcoa

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →